(VIANEWS) – The NASDAQ opens in less than one hour and Arena Pharmaceuticals‘s pre-market value is already 18.24% down.
The last session, NASDAQ Composite ended with Arena Pharmaceuticals (ARNA) dropping 2.9% to $57.55. NASDAQ Composite slid 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session.
Today’s last reported volume for Arena Pharmaceuticals is 313388, 36.32% below its average volume of 492168.
Arena Pharmaceuticals’s last close was $60.25, 33.2% under its 52-week high of $90.19.
The company’s growth estimates for the current quarter and the next is a negative 49.7% and a negative 15.7%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s current volatility was 1.53%, 3.38%, and 3.13%, respectively.
Arena Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.12% (day), 5.53% (last week), and 5.20% (last month), respectively.
More news about Arena Pharmaceuticals (ARNA).